Massimo and Apple Showdown coming soon to a screen near you-other notable Insider Buys

Learn How You Can Become an Insider Too – Click Here   The reality of significantly richer returns on risk-free assets like U.S. Treasuries has taken hold of investors’ psyches. The marginal excess returns that the stock market is likely to provide over the 10 Year Treasury are still mildly attractive. Considering the historic return of the stock market is 7.5%-8%, is the 3.7% to 4.18% risk premium above yesterday’s 3.82% 10 Year Treasury Yield worth it?  For some retired investors losing sleep over the market’s gut-wrenching volatility- the answer is clearly no.  Years of financial repression are over for … Read more

Insider Buying Week 3-11-22

Curious how well insiders are doing with their buys?  Scroll the significant buys of the last year. And what to do about the Russian Ukraine war. It will get worse and it will drag China into an ever-deepening conflict with the West and Democratic regimes. The declaration of mutual support that Russia and China published in a 5000-word memorandum entitled Joint Statement of the Russian Federation and the People’s Republic of China on the International Relations Entering a New Era and the Global Sustainable Development was reminiscent of the Axis power alignment with Germany and Japan at the onset of WWII. If we’re headed to WWW3 is that a reason … Read more

Insider Buying week 9-10-21 This is Trickery of the Highest Order

For trade, details click on this link to the trades. September is living up to its reputation as the worst-performing month of the year and we’re just getting started.  U.S. stocks fell for a fifth straight day on Friday, with the S&P 500 ending the week down 1.7 percent in its longest losing streak since February.  But that’s just a diversion from the bigger story. When the game you’re playing makes no more sense, is it time to walk away from the game? Have the rules changed in some way that’s beyond your comprehension? This is trickery of the highest … Read more

Insider Buying week 8-27-21

For trade, details click on this link to the trades.  I had a dream Friday morning about the stock market. I yelled out in my sleep, “everything is going up.” I woke up and it pretty much did exactly that. In a good market, almost all trades bounce sharply but the stickiness and real progress from there are what you have to measure. Perhaps deduct 4 or 5 percent from all the posted returns to determine your likely return as getting them at the same price or lower than the insider’s purchase cost is difficult to do since they almost … Read more

Insider Buying Picks Up Dramatically Week 8-06-21

For trade, details click on this link to the trades.  Name Sachs Bruce I Position: Director Shares Bought: 15,000 Average Price Paid: $197.91, Cost: $2,968,650 Company: Vertex Pharmaceuticals Inc. (VRTX) Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) – a rare, life-threatening genetic disease – and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule medicines in other serious diseases where it has … Read more